Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002381369 | SCV002674569 | uncertain significance | Cardiovascular phenotype | 2021-03-03 | criteria provided, single submitter | clinical testing | The p.L248P variant (also known as c.743T>C), located in coding exon 4 of the LMNA gene, results from a T to C substitution at nucleotide position 743. The leucine at codon 248 is replaced by proline, an amino acid with similar properties. This variant was reported in an individual with familial Emery-Dreifuss muscular dystrophy, who had elbow contractures and humeroperoneal myopathy with no cardiac findings (Vytopil M et al. J Med Genet, 2003 Dec;40:e132). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Epithelial Biology; Institute of Medical Biology, |
RCV000057451 | SCV000088565 | not provided | not provided | no assertion provided | not provided |